3rd Annual Formulation And Drug Delivery USA Congress

Memo

Join us to hear about the latest industry innovations at Oxford Global's Formulation and Drug Delivery USA Congress, 17 - 18 March 2020 in San Diego. Formulation and drug delivery are critical areas for the clinical adoption and commercial success of your product. With solubility and bioavailability remaining key challenges to compound safety and commercial success and with the increasing prevalence of biologics, now more than ever critical guidance is needed. Join Oxford Global for the Formulation and Drug Delivery USA Congress to hear about the latest industry innovations. With the novel biotherapeutics on the rise this congress crucially focuses on the latest updates in formulation and drug delivery for both small molecules and biologics alike. Formulation and Drug Delivery US will focus on industry topics such as new strategies for optimising biologic formulations, novel formulation strategies for small molecules and advances in small molecule and biologics drug delivery. Join industry pioneers shaping the field to discuss critical industry topics such as: • Formulation and delivery of Nanomedicines and RNA-based therapeutics • New strategies for optimising biologic formulations including antibody drug conjugates and vaccines• Novel formulation strategies for small molecules• Quality by Design (QbD) approaches• Advances in small molecule drug delivery • New biologics drug delivery systems• Cell and Gene Therapies URLs:Tickets: https://go.evvnt.com/509735-2?pid=5569Brochure: https://go.evvnt.com/509735-3?pid=5569 On Tuesday March 17, 2020 at 7:30 am (ends Wednesday March 18, 2020 at 6:00 pm) Venue details:DoubleTree by Hilton Hotel San Diego - Hotel Circle, 1515 Hotel Circle South, San Diego, 92108, United States Price:Registration Available from : GBP 299.0 Speakers: Kerstin Walke, Vice President of Pharmaceutical Development, Boehringer Ingelheim, Anand Subramony, Vice President, External Innovation and Novel Technologies, AstraZeneca, Sushrut Kulkarni, Group Vice President – Formulation and CMC, Glenmark Pharmaceuticals, Marian Gindy, Executive Director, Pharmaceutical Sciences, MSD, Evgenyi Shalaev, Executive Director, Pharmaceutical Development, Allergan, Parag Kolhe, Senior Director, Pharmaceutical Research and Development, Pfizer, Satoshi Ohtake, Senior Director of Pharmaceutical Research and Development, Pfizer